Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs
Tóm tắt
The aim of the present study was to investigate bone formation to recombinant human bone morphogenetic protein-2 (rhBMP-2)-biocoated and rhBMP-2-nonbiocoated titanium implants after implantation in dogs. Implantation of sand-blasted and acid-etched (C), chromosulfuric acid surface-enhanced (CSA), and rhBMP-2-biocoated CSA [BMP-A: noncovalently immobilized rhBMP-2 (596 ng/cm2), BMP-B: covalently immobilized rhBMP-2 (819 ng/cm2)] implants was performed in both the mandible and tibia of dogs. After 4 weeks of healing, the percentage of direct bone to implant contact (BIC) and the induced bone density (BD) at a distance of less than and greater than 1 mm adjacent to each implant was assessed. Histomorphometric analysis of implants inserted in the mandible and tibia revealed that BIC values appeared to be highest in the BMP-B group, followed by BMP-A, CSA, and C. BD as measured at a distance of <1 mm revealed obvious differences between groups: BMP-B>BMP-A>CSA>C. However, no differences between groups were observed at a distance of >1 mm. Within the limits of the present study, it may be concluded that rhBMP-2 immobilized by covalent and noncovalent methods on CSA-treated implant surfaces seemed to be stable and promoted direct bone apposition in a concentration-dependant manner.
Tài liệu tham khảo
Albrektsson T, Brånemark PI, Hansson HA, Lindstrom J (1981) Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 52:155–170
Baier RE, Dutton RC (1969) Initial events in interactions of blood with a foreign surface. J Biomed Mater Res 3:191–206
Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 17:11–25
Brash JL, ten Hove P (1984) Effect of plasma dilution on adsorption of fibrinogen to solid surfaces. Thromb Haemost 51:326–330
Chappard D, Aguado E, Hure G, Grizon F, Basle MF (1999) The early remodeling phases around titanium implants: a histomorphometric assessment of bone quality in a 3- and 6-month study in sheep. Int J Oral Maxillofac Implants 14:189–196
Chatzinikolaidou M, Zumbrink T, Jennissen HP (2003) Stability of surface-enhanced ultrahydrophilic metals as a basis for bioactive rhBMP-2 surfaces. Materialwiss Werkstofftech 34:1106–1112
Donath K (1985) The diagnostic value of the new method for the study of undecalcified bones and teeth with attached soft tissue (Säge–Schliff (sawing and grinding) technique). Pathol Res Pract 179:631–633
Eriksson C, Lausmaa J, Nygren H (2001) Interactions between human whole blood and modified TiO2-surfaces: influence of surface topography and oxide thickness on leukocyte adhesion and activation. Biomaterials 22:1987–1996
Eriksson C, Nygren H (2001) Polymorphonuclear leukocytes in coagulating whole blood recognize hydrophilic and hydrophobic titanium surfaces by different adhesion receptors and show different patterns of receptor expression. J Lab Clin Med 137:296–302
Gunsolley JC, Elswick RK, Davenport JM (1998) Equivalence and superiority testing in regeneration clinical trials. J Periodontol 69:521–527
Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjo UM (1997) Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 12:604–610
Hanisch O, Tatakis DN, Rohrer MD, Wohrle PS, Wozney JM, Wikesjo UM (1997) Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int J Oral Maxillofac Implants 12:785–792
Hollinger JO, Schmitt JM, Buck DC, Shannon R, Joh SP, Zegzula HD, Wozney J (1998) Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res 43:356–364
Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Lilly L, Cochran D (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 17:124–139
Inoda H, Yamamoto G, Hattori T (2004) Histological investigation of osteoinductive properties of rh-BMP2 in a rat calvarial bone defect model. J Craniomaxillofac Surg 32:365–369
Jennissen HP (1999) Method for immobilizing mediator molecules on inorganic and metal implant materials. PCT Patent WO9926674A2, European Patent Office, Munich, Germany
Jennissen HP (2001) Ultra-hydrophile metallische Biomaterialien. Biomaterialien 2:45–53
Jennissen HP, Chatzinikolaidou M, Rumpf HM (2000) Modification of metal surfaces and biocoating of implants with bone-morphogenetic protein 2 (BMP-2). DVM Bericht 313:127–140
Jennissen HP, Zumbrink T (1999) Immobilization of BMP-2 on titanium surfaces. Biol Chem 380:161
Jennissen HP, Zumbrink T (1999) Protein immobilization on metal implant surfaces with potential for biocoating with BMPs. FASEB J 13:427 (Abstract)
Jennissen HP, Zumbrink T, Chatzinikolaidou M, Steppuhn J (1999) Biocoating of implants with mediator molecules: surface enhancement of metals by treatment with chromosulfuric acid. Materialwiss Werkstofftech 30:838–845
Jeppsson C, Aspenberg P (1996) BMP-2 can inhibit bone healing. Bone-chamber study in rabbits. Acta Orthop Scand 67:589–592
Johansson CB, Albrektsson T (1991) A removal torque and histomorphometric study of commercially pure niobium and titanium implants in rabbit bone. Clin Oral Implants Res 2:24–29
Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Hattori Y, Koseki T, Nishihara T, Ikeda Y (2000) Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 96:2005–2011
Laub MT, Seul E, Schmachtenberg E, Jennissen HP (2001) Molecular modelling of bone-morphogenetic protein 2 (BMP-2) by 3D-rapid prototyping. Materialwiss Werkstofftech 32:926–930
Matin K, Senpuku H, Hanada N, Ozawa H, Ejiri S (2003) Bone regeneration by recombinant human bone morphogenetic protein-2 around immediate implants: a pilot study in rats. Int J Oral Maxillofac Implants 18:211–217
Mohan S, Baylink DJ (1991) Bone growth factors. Clin Orthop Relat Res 263:30–48
Nociti FH, Jr, Cesar NJ, Carvalho MD, Sallum EA (2002) Bone density around titanium implants may be influenced by intermittent cigarette smoke inhalation: a histometric study in rats. Int J Oral Maxillofac Implants 17:347–352
Reddi AH (1995) Bone morphogenetic proteins, bone marrow stromal cells, and mesenchymal stem cells. Maureen Owen revisited. Clin Orthop Relat Res 313:115–119
Ritter SJ, Davies PJ (1998) Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J Biol Chem 273:12798–12806
Sailer HF, Kolb E (1994) Application of purified bone morphogenetic protein (BMP) preparations in cranio-maxillo-facial surgery. Reconstruction in craniofacial malformations and post-traumatic or operative defects of the skull with lyophilized cartilage and BMP. J Craniomaxillofac Surg 22:191–199
Schmaier AH, Silver L, Adams AL, Fischer GC, Munoz PC, Vroman L, Colman RW (1984) The effect of high molecular weight kininogen on surface-adsorbed fibrinogen. Thromb Res 33:51–67
Sigurdsson TJ, Nygaard L, Tatakis DN, Fu E, Turek TJ, Jin L, Wozney JM, Wikesjo UM (1996) Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 16:524–537
Sykaras N, Triplett RG, Nunn ME, Iacopino AM, Opperman LA (2001) Effect of recombinant human bone morphogenetic protein-2 on bone regeneration and osseointegration of dental implants. Clin Oral Implants Res 12:339–349
Sykaras N, Iacopino AM, Triplett RG, Marker VA (2004) Effect of recombinant human bone morphogenetic protein-2 on the osseointegration of dental implants: a biomechanics study. Clin Oral Investig 8:196–205
Sykaras N, Woody RD, Lacopino AM, Triplett RG, Nunn ME (2004) Osseointegration of dental implants complexed with rhBMP-2: a comparative histomorphometric and radiographic evaluation. Int J Oral Maxillofac Implants 19:667–678
Tatakis DN, Koh A, Jin L, Wozney JM, Rohrer MD, Wikesjo UM (2002) Peri-implant bone regeneration using recombinant human bone morphogenetic protein-2 in a canine model: a dose-response study. J Periodontal Res 37:93–100
Teixeira JO, Urist MR (1998) Bone morphogenetic protein induced repair of compartmentalized segmental diaphyseal defects. Arch Orthop Trauma Surg 117:27–34
Urist MR, DeLange RJ, Finerman GA (1983) Bone cell differentiation and growth factors. Science 220:680–686
Voggenreiter GK, Hartl M, Assenmacher S, Chatzinikolaidou M, Jennissen HP, Rumpf HM (2001) Assessment of the biological activity of chemically immobilized rhBMP-2 on titanium surfaces in vivo. Materialwiss Werkstofftech 32:942–948
Walivaara B, Aronsson BO, Rodahl M, Lausmaa J, Tengvall P (1994) Titanium with different oxides: in vitro studies of protein adsorption and contact activation. Biomaterials 15:827–834
Walivaara B, Askendal A, Elwing H, Lundstrom I, Tengvall P (1992) Antisera binding onto metals immersed in human plasma in vitro. J Biomed Mater Res 26:1205–1216
Wiemann M, Rumpf HM, Bingmann D, Jennissen HP (2001) The binding of rhBMP-2 to the receptors of MC3T3-E1 cells and the question of cooperativity. Materialwiss Werkstofftech 32:931–936
Wiemann M, Zumbrink T, Jennissen HP, Brauer H, Fischer A, Bingmann D (1999) BMP-2 stimulation of osteoblast-like MC3T3-E1 cells grown on modified metal surfaces. Pflügers Arch 437:R106
Wikesjö UM, Sorensen RG, Kinoshita A, Wozney JM (2002) RhBMP-2/alphaBSM induces significant vertical alveolar ridge augmentation and dental implant osseointegration. Clin Implant Dent Relat Res 4:174–182
Wozney JM, Rosen V, Byrne M, Celeste AJ, Moutsatsos I, Wang EA (1990) Growth factors influencing bone development. J Cell Sci Suppl 13:149–156
Yamazaki Y, Oida S, Ishihara K, Nakabayashi N (1996) Ectopic induction of cartilage and bone by bovine bone morphogenetic protein using a biodegradable polymeric reservoir. J Biomed Mater Res 30:1–4
Yoshida K, Bessho K, Fujimura K, Kusumoto K, Ogawa Y, Tani Y, Iizuka T (1998) Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. J Craniomaxillofac Surg 26:112–115
Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO (1997) Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 79:1778–1790
Zellin G, Linde A (1997) Treatment of segmental defects in long bones using osteopromotive membranes and recombinant human bone morphogenetic protein-2. An experimental study in rabbits. Scand J Plast Reconstr Surg Hand Surg 31:97–104